Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Abstract

Objective.-To develop an evidence-based reporting data set for each cancer site.Design.-A project to develop data sets for prostate, endometrium, and lung cancers and malignant melanoma was piloted by the quadripartite group.Results.-A set of required and recommended data elements and appropriate responses for each element were agreed upon for the reporting of lung cancer.Conclusions.-This review describes the process of development of the lung cancer data set.

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

“…The ICCR has developed and ratified a suite of standard operating procedures for the process of data set development (described in earlier publications [1][2][3][4] and also defined the selection process, roles and responsibilities of the chair, expert panel members, the ICCR Steering Committee representative on the panel and the project manager.…”

“…The process of production of each of these data sets has been published in peerreviewed journals. [1][2][3][4] The ICCR is currently in the process of becoming incorporated that will facilitate financial support of an expanded membership and allow the continued development of high-quality cancer data sets for international use. The founding members include the original quadripartite group together with the European Society of Pathology.…”

Comparison of Accuracy and Speed of Information Identification by Nonpathologists in Synoptic Reports With Different Formats

“…As previously mentioned, there is an abundance of evidence that mandating and requiring a specific list of elements for inclusion in synoptic reporting, along with the provision of a checklist of those items, can successfully improve the completeness of reports. [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33] There are also published data concerning the accuracy of the data included in a synoptic report. Specifically, the words no and not are rarely but consistently left off of reports reducing accuracy, and ensuring that the phrases in the checklist contain as few of these elements as possible improves accuracy.…”

“…The CAP specifically requires that each element in a synoptic report be reported in a required data element (RDE) pair consisting of the element and the corresponding response (CAP Laboratory Accreditation Process Checklist question ANP.12385). 1 While there are significant data supporting the use of checklists in general, 2-14 and their use to improve the completeness of surgical pathology reporting specifically, [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33] there are much fewer data concerning the significance of the specific formats. Valenstein 34 examined structured reporting and focused on diagnostic headlines, white space, standardized layout, continuity over time, and reduction of clutter but provided few data addressing the specific formats.…”

Impact of Recent Developments in Lung Cancer on the Practice of Pathology

“…8 This is in keeping with current pathology practice that was already distinguishing between adenocarcinoma and squamous cell carcinoma on the basis of IHC in the absence of strict routine histologic criteria. [14][15][16][17][18][19][20][21][22][23] Recent advances in lung cancer therapy, including the use of tyrosine kinase inhibitors, are closely associated with specific lung cancer cell types (adenocarcinoma versus squamous cell carcinoma). 24 This has led to proposals to use IHC to further classify lung cancers previously classified as large cell carcinoma to guide therapy and to minimize the diagnosis of NSCLC when possible.…”